JUBILANT PHARMOVA
Back to Income Statement
|
JUBILANT PHARMOVA Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹6,282 Cr | ₹6,130 Cr | ₹6,099 Cr | ₹5,976 Cr | ₹9,111 Cr |
What is the latest Revenue of JUBILANT PHARMOVA ?
Year | Revenue |
---|---|
Mar2024 | ₹6,282 Cr |
Mar2023 | ₹6,130 Cr |
Mar2022 | ₹6,099 Cr |
Mar2021 | ₹5,976 Cr |
Mar2020 | ₹9,111 Cr |
How is Revenue of JUBILANT PHARMOVA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹6,282 Cr | 2.47 | |
Mar2023 | ₹6,130 Cr | 0.52 | |
Mar2022 | ₹6,099 Cr | 2.05 | |
Mar2021 | ₹5,976 Cr | -34.41 | |
Mar2020 | ₹9,111 Cr | - |
Compare Revenue of peers of JUBILANT PHARMOVA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JUBILANT PHARMOVA | ₹18,488.4 Cr | -1.1% | -3.4% | 54.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
JUBILANT PHARMOVA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JUBILANT PHARMOVA | -1.1% |
-3.4% |
54.1% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses